The Effect of Serotonin 5-HT2C Receptor Modulation on Binge Drinking and Alcohol-Seeking in Female Mice

IF 2.6 3区 医学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Roberta G. Anversa, Linh Tran, Andrew A. Bolinger, Jia Zhou, Kathryn A. Cunningham, Andrew J. Lawrence, Erin J. Campbell
{"title":"The Effect of Serotonin 5-HT2C Receptor Modulation on Binge Drinking and Alcohol-Seeking in Female Mice","authors":"Roberta G. Anversa,&nbsp;Linh Tran,&nbsp;Andrew A. Bolinger,&nbsp;Jia Zhou,&nbsp;Kathryn A. Cunningham,&nbsp;Andrew J. Lawrence,&nbsp;Erin J. Campbell","doi":"10.1111/adb.70099","DOIUrl":null,"url":null,"abstract":"<p>Alcohol misuse remains a leading cause of preventable death worldwide, prompting research into novel pharmacotherapies for alcohol use disorder (AUD). This study investigated the therapeutic potential of full agonism or positive allosteric modulation of the serotonin 2C receptor (5-HT<sub>2C</sub>R) in addressing alcohol binge drinking and seeking behaviours in mice. Using a drinking-in-the-dark paradigm and a context-induced reinstatement model following punishment-imposed abstinence, we assessed the acute effects of 5-HT<sub>2C</sub>R ligands lorcaserin, CYD-1-79, VA012 and CTW0415 on alcohol intake and seeking behaviours in mice. Results showed that while lorcaserin effectively reduced both alcohol consumption and seeking behaviours, the 5-HT<sub>2C</sub>R positive allosteric modulators (PAMs) did not significantly alter these behaviours over the range of doses examined. These findings suggest that 5-HT<sub>2C</sub>R PAMs, at the tested doses, may lack intrinsic efficacy in modulating alcohol use. However, our lorcaserin data demonstrate that targeting 5-HT<sub>2C</sub>R remains a valid approach to reduce behaviours associated with AUD.</p>","PeriodicalId":7289,"journal":{"name":"Addiction Biology","volume":"30 11","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12602058/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction Biology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/adb.70099","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Alcohol misuse remains a leading cause of preventable death worldwide, prompting research into novel pharmacotherapies for alcohol use disorder (AUD). This study investigated the therapeutic potential of full agonism or positive allosteric modulation of the serotonin 2C receptor (5-HT2CR) in addressing alcohol binge drinking and seeking behaviours in mice. Using a drinking-in-the-dark paradigm and a context-induced reinstatement model following punishment-imposed abstinence, we assessed the acute effects of 5-HT2CR ligands lorcaserin, CYD-1-79, VA012 and CTW0415 on alcohol intake and seeking behaviours in mice. Results showed that while lorcaserin effectively reduced both alcohol consumption and seeking behaviours, the 5-HT2CR positive allosteric modulators (PAMs) did not significantly alter these behaviours over the range of doses examined. These findings suggest that 5-HT2CR PAMs, at the tested doses, may lack intrinsic efficacy in modulating alcohol use. However, our lorcaserin data demonstrate that targeting 5-HT2CR remains a valid approach to reduce behaviours associated with AUD.

Abstract Image

5-羟色胺5-HT2C受体调节对雌性小鼠酗酒和嗜酒的影响。
酒精滥用仍然是世界范围内可预防死亡的主要原因,促进了对酒精使用障碍(AUD)的新型药物治疗的研究。本研究探讨了5-羟色胺2C受体(5-HT2CR)的完全激动作用或正变构调节在解决小鼠酗酒和寻找行为中的治疗潜力。使用黑暗中饮酒范式和情境诱导的戒断后恢复模型,我们评估了5-HT2CR配体氯卡色林、CYD-1-79、VA012和CTW0415对小鼠酒精摄入和寻找行为的急性影响。结果表明,虽然氯卡色林有效地减少了酒精消耗和寻找行为,但在检测的剂量范围内,5-HT2CR阳性变构调节剂(pam)并没有显著改变这些行为。这些发现表明,在测试剂量下,5-HT2CR PAMs可能缺乏调节酒精使用的内在功效。然而,我们的氯卡色林数据表明,靶向5-HT2CR仍然是减少AUD相关行为的有效方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Addiction Biology
Addiction Biology 生物-生化与分子生物学
CiteScore
8.10
自引率
2.90%
发文量
118
审稿时长
6-12 weeks
期刊介绍: Addiction Biology is focused on neuroscience contributions and it aims to advance our understanding of the action of drugs of abuse and addictive processes. Papers are accepted in both animal experimentation or clinical research. The content is geared towards behavioral, molecular, genetic, biochemical, neuro-biological and pharmacology aspects of these fields. Addiction Biology includes peer-reviewed original research reports and reviews. Addiction Biology is published on behalf of the Society for the Study of Addiction to Alcohol and other Drugs (SSA). Members of the Society for the Study of Addiction receive the Journal as part of their annual membership subscription.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书